These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20299233)

  • 1. Immunoreactivity of integrin-linked kinase in primary non-small-cell lung cancer and survival after curative resection.
    Watzka SB; Rauscher-Pötsch I; Stubenberger E; Getman V; Setinek U; Tötsch M; Pötschger U; Müller MR
    Eur J Cardiothorac Surg; 2010 Sep; 38(3):254-9. PubMed ID: 20299233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
    Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
    Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients.
    Enatsu S; Yoshida J; Yokose T; Nishimura M; Nishiwaki Y; Shirakusa T; Nagai K
    Ann Thorac Surg; 2006 Jan; 81(1):298-304. PubMed ID: 16368385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
    Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
    Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of a biologic classification of non-small-cell lung cancer into the growth patterns along with other clinical, pathological and immunohistochemical factors.
    Sardari Nia P; Van Marck E; Weyler J; Van Schil P
    Eur J Cardiothorac Surg; 2010 Nov; 38(5):628-36. PubMed ID: 20452237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
    Watanabe S; Asamura H; Suzuki K; Tsuchiya R
    Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
    D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
    Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the proposals of the international association for the study of lung cancer in the forthcoming edition of lung cancer staging system to predict long-term prognosis of operated patients.
    Rena O; Massera F; Robustellini M; Papalia E; Delfanti R; Lisi E; Pirondini E; Turello D; Casadio C
    Cancer J; 2010; 16(2):176-81. PubMed ID: 20404615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD98 expression is associated with poor prognosis in resected non-small-cell lung cancer with lymph node metastases.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Kamide Y; Ishizuka T; Kanai Y; Nakajima T; Mori M
    Ann Surg Oncol; 2009 Dec; 16(12):3473-81. PubMed ID: 19777189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative pleural lavage: is it a valid prognostic factor in lung cancer?
    Vicidomini G; Santini M; Fiorello A; Parascandolo V; Calabrò B; Pastore V
    Ann Thorac Surg; 2005 Jan; 79(1):254-7; discussion 254-7. PubMed ID: 15620952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer.
    Marchetti A; Bertacca G; Buttitta F; Chella A; Quattrocolo G; Angeletti CA; Bevilacqua G
    Clin Cancer Res; 1999 Aug; 5(8):2077-81. PubMed ID: 10473089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
    Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
    Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
    In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in stereotactic body radiotherapy for non-small-cell lung cancer.
    Matsuo Y; Shibuya K; Nagata Y; Takayama K; Norihisa Y; Mizowaki T; Narabayashi M; Sakanaka K; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1104-11. PubMed ID: 20472343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of patients in stage I and II primary lung cancer with curative resection].
    Nishimura H; Morimoto M; Haniuda M; Masai M; Kobayashi O; Yamanda T; Aoki T; Iida F
    Kyobu Geka; 1992 Jul; 45(7):582-5. PubMed ID: 1320146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.